NSE › Healthcare

Gufic Biosciences Limited (GUFICBIO)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹390.50+3.08%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹252 cr
Revenue YoY
+22.8%
Net profit
₹22 cr
Profit YoY
+183.6%
EPS
₹0.51
EPS estimate
₹0.61
Net margin
8.7%

EPS came in at 0.51 against a street estimate of 0.61 — a miss of 16.4%.

Key statistics

Market cap
₹3,921 cr
P/E
61.2
Forward P/E
0.0
P/B
5.88
Book value
₹66.20
EPS (TTM)
₹6.39
Dividend yield
0.03%
52-week high
₹448.00
52-week low
₹268.00
50-day MA
₹371.99
200-day MA
₹326.96
Beta
-0.04

Shareholding

Promoters
77.55%
Institutions
3.68%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Gufic Biosciences Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.